'Designer Baby' Patent Draws Ethical Scrutiny

Saturday, 05 Oct 2013 09:27 AM

 

Share:
A    A   |
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink

European bioethicists raised the red flag Thursday over an American patent for a method that could allow people to choose genetic traits like eye colour in children sired from donor eggs or sperm.

The patent for what is called a "gamete (egg or sperm) donor selection" method, was granted by the US Patent and Trademark Office (USPTO) to the firm 23andMe on Sept. 24.

A description on the USPTO website said the "technique allows the potential gamete recipients to make more informed donor choices".

"What 23andMe is claiming is a method by which prospective donors of ova and/or sperm may be selected so as to increase the likelihood of producing a human baby with characteristics desired by the prospective parents," said the commentary by medical ethicists from Belgium, the Netherlands and France published in the journal Genetics in Medicine.

This would be based on a computerised comparison of the genomic data of the egg provider with that of the sperm provider.

Characteristics on the parents' "shopping list" could include height, eye colour, muscle development, personality traits, or risk of developing certain types of cancer and other diseases, said the commentators.

A figure attached to the patent application would allow prospective parents to indicate whether "I prefer a child with": "longest expected life span", "least expected life cost of health care", or "least expected cumulative duration of hospitalisation", they said.

There were also options for "zero percent likely endurance athlete" and "100 percent likely sprinter", though the company had stated it could not guarantee the outcome but merely boost the chances of a child having the desired traits.

The commentators describe the method as "hugely ethically controversial" -- particularly as it allows for the selection of characteristics that have nothing to do with the child's health.

"At no stage during the examination of the patent application did the patent office examiner question whether techniques for facilitating the 'design' of future human babies were appropriate subject matter for a patent," they wrote.

The USPTO said it did not comment on issued patents.

23forMe said the patent, applied for more than five years ago, was for a tool dubbed Family Traits Inheritance Calculator that offered "an engaging way for you and your partner to see what kind of traits your child might inherit from you" -- from eye colour to whether the child will be able to perceive bitter taste or be lactose intolerant.

The language of the patent was much broader than the technology to support the calculator, the company said in a blog on its website.

"At the time 23andMe filed the patent, there was consideration that the technology could have potential applications for fertility clinics, so language specific to the fertility treatment process was included," it said.

"The company never pursued the concepts discussed in the patent beyond our Family Traits Inheritance Calculator, nor do we have any plans to do so."

mlr/gk

© AFP 2014

Share:
   Email Us   |
   Print   |
   Forward Article  |
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Study: Even Casually Smoking Marijuana Can Change Your Brain

Wednesday, 16 Apr 2014 14:26 PM

Casual use of marijuana can produce changes in parts of the brain associated with emotion and motivation, according to a . . .

Scientist Apologizes for Mistakes in Stem Cell Research

Wednesday, 16 Apr 2014 13:29 PM

A Japanese scientist who co-authored what was deemed breakthrough stem cell research issued an apology Wednesday over mi . . .

US Wins More Guilty Pleas in First Counterfeit Apps Case

Tuesday, 15 Apr 2014 18:45 PM

The final defendants in what the U.S. government called its first prosecution of a counterfeit apps case have pleaded gu . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved